StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
46
This year
1
Publishing Date
2024 - 01 - 24
1
2023 - 08 - 17
1
2023 - 07 - 18
1
2023 - 06 - 21
1
2023 - 06 - 02
1
2023 - 05 - 22
1
2023 - 05 - 15
1
2023 - 05 - 10
1
2023 - 05 - 04
1
2023 - 04 - 17
1
2023 - 03 - 29
1
2023 - 01 - 10
1
2022 - 11 - 02
1
2022 - 10 - 26
1
2022 - 08 - 24
1
2022 - 08 - 04
1
2022 - 07 - 28
1
2022 - 06 - 02
1
2022 - 05 - 18
1
2022 - 05 - 11
1
2022 - 05 - 04
1
2022 - 03 - 01
1
2022 - 02 - 23
1
2022 - 01 - 28
1
2022 - 01 - 14
1
2022 - 01 - 03
1
2021 - 11 - 11
1
2021 - 11 - 08
1
2021 - 11 - 02
1
2021 - 10 - 26
1
2021 - 10 - 19
1
2021 - 10 - 06
1
2021 - 08 - 27
1
2021 - 08 - 24
1
2021 - 08 - 23
1
2021 - 08 - 04
1
2021 - 08 - 03
1
2021 - 06 - 25
1
2021 - 06 - 24
1
2021 - 05 - 25
1
2021 - 05 - 20
1
2021 - 05 - 17
1
2021 - 05 - 10
1
2021 - 04 - 26
1
2021 - 03 - 25
1
2021 - 03 - 23
1
Sector
Health services
2
Health technology
46
Tags
Alliances
3
Als
4
Biopharma
2
Biotechnology
9
Bos-342
1
Business
2
Cancer
2
Cd228
1
Clinical-trials-phase-ii
2
Collaboration
2
Conference
5
Covid
1
Designation
1
Drug
1
Earnings
9
Events
9
Extension
1
Fibrosis
1
Financial
3
Financial results
4
Genetown
1
Gpt-3
1
Her2
1
Her2-
1
International
1
Key
1
License
1
Meeting
1
Milestone
3
N/a
1
People
7
Pharmaceuticals
12
Phase 1
1
Phase 2
2
Phase 2b
1
Positive
1
Pre-clinical
1
Preclinical
3
Presentation
4
Product-news
1
Prs-060
3
Prs-343
1
Prs-400
2
Report
1
Research
4
Respiratory
1
Results
9
Review
1
Spac
1
Space
1
Study
2
Therapeutics
2
Treatment
1
Trial
6
Update
5
Entities
Abbott laboratories
1
Acadia pharmaceuticals inc.
1
F-star therapeutics inc.
2
Fulcrum therapeutics, inc.
2
Genocea biosciences, inc.
1
Guardant health, inc.
2
Htg molecular diagnostics, inc.
1
Ibio, inc.
1
Johnson & johnson
1
Novartis ag
1
Orchard therapeutics plc
2
Pieris pharmaceuticals, inc.
46
Sanofi
2
Soleno therapeutics, inc.
1
T2 biosystems, inc.
2
Vanda pharmaceuticals inc.
1
Vaxart, inc.
1
Voyager therapeutics, inc.
2
Symbols
AAPL
1197
ABB
1204
ABBV
608
ABLZF
1166
ABT
1074
ACAQ
522
AMGN
742
AMSIY
465
AMSYF
465
ARCXF
465
ARVL
4294
AVGO
586
AZN
665
BNPQF
1764
BNPQY
1764
CRCW
473
CSCO
897
DNZOF
504
DNZOY
504
ERIC
1612
EXTR
581
FNCTF
7190
FRBA
598
GE
508
GILD
500
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
811
HON
1026
IFNNF
525
IFNNY
503
INTC
955
JNJ
2072
LLY
1088
LTUM
971
MAR
474
MDT
731
MS
1788
MSFT
1201
MT
473
NIPNF
533
NOK
859
NOKBF
975
NVDA
517
NVS
1156
NVSEF
1031
ORCL
787
PCRFF
650
PCRFY
650
PHG
476
PPRUF
1128
PPRUY
1129
SAP
1379
SAPGF
1231
SNY
4539
SNYNF
3597
TEVJF
631
TMO
705
VSAC
534
Exchanges
Amex
1
Nasdaq
46
Nyse
3
Crawled Date
2024 - 01 - 24
1
2023 - 08 - 17
1
2023 - 07 - 18
1
2023 - 06 - 21
1
2023 - 06 - 02
1
2023 - 05 - 22
1
2023 - 05 - 15
1
2023 - 05 - 10
1
2023 - 05 - 04
1
2023 - 04 - 17
1
2023 - 03 - 29
1
2023 - 01 - 10
1
2022 - 11 - 02
1
2022 - 10 - 26
1
2022 - 08 - 24
1
2022 - 08 - 04
1
2022 - 07 - 28
1
2022 - 06 - 02
1
2022 - 05 - 18
1
2022 - 05 - 11
1
2022 - 05 - 04
1
2022 - 03 - 01
1
2022 - 02 - 23
1
2022 - 01 - 28
1
2022 - 01 - 14
1
2022 - 01 - 03
1
2021 - 11 - 11
1
2021 - 11 - 08
1
2021 - 11 - 02
1
2021 - 10 - 26
1
2021 - 10 - 19
1
2021 - 10 - 06
1
2021 - 08 - 27
1
2021 - 08 - 24
2
2021 - 08 - 04
1
2021 - 08 - 03
1
2021 - 06 - 25
1
2021 - 06 - 24
1
2021 - 05 - 25
1
2021 - 05 - 20
1
2021 - 05 - 17
1
2021 - 05 - 10
1
2021 - 04 - 26
1
2021 - 03 - 25
1
2021 - 03 - 23
1
Crawled Time
00:00
1
10:00
1
12:00
11
12:15
1
12:20
4
12:30
2
13:00
12
13:15
1
13:20
2
13:30
1
14:00
4
15:00
2
16:00
1
17:00
1
19:00
1
22:00
1
Source
www.biospace.com
45
www.globenewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
PIRS
exchanges :
Nasdaq
save search
Soleno Therapeutics Strengthens Leadership Team with Key Appointments
Published:
2024-01-24
(Crawled : 13:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.09%
|
O:
-3.01%
H:
0.69%
C:
-0.75%
VYGR
|
$7.5
-0.66%
-0.67%
520K
|
Health Technology
|
-0.26%
|
O:
1.19%
H:
0.33%
C:
-2.61%
SLNO
4
|
$36.99
-0.43%
100K
|
Health Technology
|
-22.72%
|
O:
-1.62%
H:
1.53%
C:
-2.07%
SNY
|
News
|
$46.385
2.19%
3M
|
Health Technology
|
-9.13%
|
O:
0.92%
H:
0.0%
C:
0.0%
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-4.42%
|
O:
-3.23%
H:
4.2%
C:
-1.3%
FULC
|
$6.79
-3.82%
390K
|
Health Technology
|
6.4%
|
O:
1.04%
H:
2.28%
C:
-1.33%
key
therapeutics
Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
Published:
2023-08-17
(Crawled : 13:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-33.5%
|
O:
5.11%
H:
10.24%
C:
2.81%
bos-342
pharmaceuticals
milestone
study
Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
Published:
2023-07-18
(Crawled : 13:20)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-14.53%
|
O:
33.55%
H:
47.44%
C:
-16.28%
update
pharmaceuticals
Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study
Published:
2023-06-21
(Crawled : 12:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-82.12%
|
O:
-58.66%
H:
5.38%
C:
-29.51%
prs-060
pharmaceuticals
trial
study
Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference
Published:
2023-06-02
(Crawled : 22:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-81.18%
|
O:
0.0%
H:
5.88%
C:
5.35%
conference
pharmaceuticals
Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference
Published:
2023-05-22
(Crawled : 14:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-80.46%
|
O:
1.34%
H:
4.59%
C:
4.59%
prs-400
conference
presentation
international
pharmaceuticals
preclinical
OMass Therapeutics Announces Appointment of New Board Chair and Series B Extension
Published:
2023-05-15
(Crawled : 10:00)
- biospace.com/
VYGR
|
$7.5
-0.66%
-0.67%
520K
|
Health Technology
|
-27.68%
|
O:
-0.86%
H:
0.97%
C:
0.48%
SNY
|
News
|
$46.385
2.19%
3M
|
Health Technology
|
-15.86%
|
O:
0.38%
H:
0.0%
C:
0.0%
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-81.4%
|
O:
0.0%
H:
4.64%
C:
0.57%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
223.54%
|
O:
6.61%
H:
4.01%
C:
-1.82%
FULC
|
$6.79
-3.82%
390K
|
Health Technology
|
118.65%
|
O:
4.28%
H:
7.62%
C:
6.74%
extension
therapeutics
Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates
Published:
2023-05-10
(Crawled : 12:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-81.18%
|
O:
-1.76%
H:
4.19%
C:
2.99%
business
pharmaceuticals
financial
results
Pieris Pharmaceuticals Announces Successful Completion of Safety Review for 10 mg Dose of Phase 2a Trial of Elarekibep (PRS-060/AZD1402)
Published:
2023-05-04
(Crawled : 13:20)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-80.46%
|
O:
0.7%
H:
5.53%
C:
-2.97%
prs-060
review
pharmaceuticals
trial
Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting
Published:
2023-04-17
(Crawled : 13:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-77.72%
|
O:
10.01%
H:
5.32%
C:
4.43%
prs-343
presentation
positive
pharmaceuticals
meeting
Pieris Pharmaceuticals Reports Full-Year 2022 Financial Results and Business Updates
Published:
2023-03-29
(Crawled : 12:20)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-89.19%
|
O:
-25.68%
H:
17.27%
C:
-3.64%
business
pharmaceuticals
financial
results
Pieris Pharmaceuticals Announces $5 Million Milestone from Seagen for Initiation of Phase 1 Trial of CD228 x 4-1BB Bispecific Molecule (Mabcalin SGN-BB228 (PRS-346)
Published:
2023-01-10
(Crawled : 14:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-87.5%
|
O:
4.69%
H:
5.97%
C:
5.22%
cd228
pharmaceuticals
trial
milestone
Pieris Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published:
2022-11-02
(Crawled : 12:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-84.91%
|
O:
0.94%
H:
5.61%
C:
-4.67%
pharmaceuticals
financial
update
results
Pieris Pharmaceuticals To Host Third Quarter 2022 Investor Call and Provide Corporate Update on November 2, 2022
Published:
2022-10-26
(Crawled : 13:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-84.31%
|
O:
-1.96%
H:
6.0%
C:
2.0%
pharmaceuticals
update
Pieris Pharmaceuticals Announces Presentation of Preclinical Data for Inhaled Jagged-1 Inhibitor PRS-400 at ERS
Published:
2022-08-24
(Crawled : 13:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-89.33%
|
O:
3.33%
H:
3.23%
C:
1.94%
prs-400
preclinical
presentation
Pieris Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published:
2022-08-04
(Crawled : 12:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-91.21%
|
O:
-2.2%
H:
1.12%
C:
-3.37%
update
results
Pieris Pharmaceuticals to Host Second Quarter 2022 Investor Call and Provide Corporate Update on August 4, 2022
Published:
2022-07-28
(Crawled : 12:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-91.21%
|
O:
-0.55%
H:
2.21%
C:
-0.55%
update
Pieris Pharmaceuticals To Present at Jefferies Healthcare Conference
Published:
2022-06-02
(Crawled : 12:20)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-91.16%
|
O:
-3.87%
H:
8.62%
C:
5.17%
conference
Pieris Pharmaceuticals To Present at H.C. Wainwright Global Investment Conference
Published:
2022-05-18
(Crawled : 12:20)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-90.64%
|
O:
3.51%
H:
2.26%
C:
-1.69%
conference
Pieris Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Published:
2022-05-11
(Crawled : 12:00)
- biospace.com/
PIRS
|
$0.1455
-6.25%
-6.67%
1.9M
|
Health Technology
|
-92.79%
|
O:
0.45%
H:
0.0%
C:
-19.73%
results
← Previous
1
2
3
Next →
Gainers vs Losers
58%
42%
Top 10 Gainers
AGBA
|
News
|
$1.305
226.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
PAPL
|
$1.435
-12.5%
1.1M
|
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
NVFY
|
$2.65
25.59%
33M
|
Consumer Durables
INSG
|
$3.03
25.21%
330K
|
Electronic Technology
KNW
4
|
$0.59
-0.71%
18.64%
27K
|
Manufacturing
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
ASNS
|
$0.828
21.75%
17.86%
18K
|
UONE
|
$2.36
19.8%
16.53%
75K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.